Hanna Katarina Lilith Johansson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hanna Katarina Lilith Johansson has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Terje Svingen
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
10 shared publications - Julie Boberg
Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kgs. Lyngby, DK-2800, Denmark
6 shared publications - Sofie Christiansen
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
5 shared publications - Anne-Simone Parent
Neuroendocrinology Unit, GIGA Neurosciences, University of Liège, Liège, Belgium
3 shared publications - Monica Kam Draskau
National Food Institute, Technical University of Denmark, Lyngby, Denmark
3 shared publications - Panagiotis Filis
Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 139 (6)
An Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps
Adverse outcome pathways (AOPs) are pragmatic descriptions of how molecular perturbations can lead to adverse effects in intact organisms. To examine connectivity across endocrine signalling pathways, we integrated 117 AOPs related to oestrogen, androgen, steroidogenesis, thyroid and retinoic acid (EATS,R) modalities into a unified endocrine AOP network (AOPN). The resulting network revealed uneven pathway representation, limited mechanistic integration across EATS,R modalities and substantial gaps in certain signalling coverage, with only six retinoic acid‐related AOPs available for integration. At the same time, the AOPN identified highly connected biological nodes linking multiple pathways to adverse outcomes, highlighting potential points of endocrine crosstalk as well as cross‐species key events (KEs), bridging human and environmental health. To strengthen retinoid pathway integration, new KEs describing altered retinoic acid receptor activation were developed as potential network hubs (KE 2419 and KE 2420). Collectively, these findings demonstrate how the AOPN reveals emergent biological relationships, exposes knowledge gaps and identifies candidate targets for NAM development, providing a framework that could be used to prioritise future AOP development, and overall, to support a more integrated, system‐level approach to endocrine disruptor identification.
- 13 November 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 139 (6)
Open AccessAn Integrated Network of Classical Endocrine and Retinoic Acid Pathways Reveals Points of Convergence and Knowledge Gaps
Adverse outcome pathways (AOPs) are pragmatic descriptions of how molecular perturbations can lead to adverse effects in intact organisms. To examine connectivity across endocrine signalling pathways, we integrated 117 AOPs related to oestrogen, androgen, steroidogenesis, thyroid and retinoic acid (EATS,R) modalities into a unified endocrine AOP network (AOPN). The resulting network revealed uneven pathway representation, limited mechanistic integration across EATS,R modalities and substantial gaps in certain signalling coverage, with only six retinoic acid‐related AOPs available for integration. At the same time, the AOPN identified highly connected biological nodes linking multiple pathways to adverse outcomes, highlighting potential points of endocrine crosstalk as well as cross‐species key events (KEs), bridging human and environmental health. To strengthen retinoid pathway integration, new KEs describing altered retinoic acid receptor activation were developed as potential network hubs (KE 2419 and KE 2420). Collectively, these findings demonstrate how the AOPN reveals emergent biological relationships, exposes knowledge gaps and identifies candidate targets for NAM development, providing a framework that could be used to prioritise future AOP development, and overall, to support a more integrated, system‐level approach to endocrine disruptor identification.
- Open Access
- 13 October 2025
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 164, 105965
Using read-across to identify isobutylparaben as an endocrine disruptor
- 13 October 2025
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 164, 105965
Open AccessUsing read-across to identify isobutylparaben as an endocrine disruptor
- Open Access
- 3 October 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1126485
Comparison of female rat reproductive effects of pubertal versus adult exposure to known endocrine disruptors
A prevailing challenge when testing chemicals for their potential to cause female reproductive toxicity is the lack of appropriate toxicological test methods. We hypothesized that starting a 28-day in vivo toxicity study already at weaning, instead of in adulthood, would increase the sensitivity to detect endocrine disruptors due to the possibility of including assessment of pubertal onset. We compared the sensitivity of two rat studies using pubertal or adult exposure. We exposed the rats to two well-known human endocrine disruptors, the estrogen diethylstilbestrol (DES; 0.003, 0.012, 0.048 mg/kg bw/day) and the steroid synthesis inhibitor ketoconazole (KTZ; 3, 12, 48 mg/kg bw/day). Specifically, we addressed the impact on established endocrine-sensitive endpoints including day of vaginal opening (VO), estrous cyclicity, weights of reproductive organs and ovarian histology. After 28 days of exposure, starting either at weaning or at 9 weeks of age, DES exposure altered estrous cyclicity, reduced ovary weight as well as number of antral follicles and corpora lutea. By starting exposure at weaning, we could detect advanced day of VO in DES-exposed animals despite a lower body weight. Some endpoints were affected mainly with adult exposure, as DES increased liver weights in adulthood only. For KTZ, no effects were seen on time of VO, but adrenal and liver weights were increased in both exposure scenarios, and adult KTZ exposure also stimulated ovarian follicle growth. At first glance, this would indicate that a pubertal exposure scenario would be preferrable as timing of VO may serve as sensitive indicator of endocrine disruption by estrogenic mode of action. However, a higher sensitivity for other endocrine targets may be seen starting exposure in adulthood. Overall, starting a 28-day study at weaning with inclusion of VO assessment would mainly be recommended for substances showing estrogenic potential e.g., in vitro, whereas for other substances an adult exposure scenario may be recommended.
- 3 October 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1126485
Open AccessComparison of female rat reproductive effects of pubertal versus adult exposure to known endocrine disruptors
A prevailing challenge when testing chemicals for their potential to cause female reproductive toxicity is the lack of appropriate toxicological test methods. We hypothesized that starting a 28-day in vivo toxicity study already at weaning, instead of in adulthood, would increase the sensitivity to detect endocrine disruptors due to the possibility of including assessment of pubertal onset. We compared the sensitivity of two rat studies using pubertal or adult exposure. We exposed the rats to two well-known human endocrine disruptors, the estrogen diethylstilbestrol (DES; 0.003, 0.012, 0.048 mg/kg bw/day) and the steroid synthesis inhibitor ketoconazole (KTZ; 3, 12, 48 mg/kg bw/day). Specifically, we addressed the impact on established endocrine-sensitive endpoints including day of vaginal opening (VO), estrous cyclicity, weights of reproductive organs and ovarian histology. After 28 days of exposure, starting either at weaning or at 9 weeks of age, DES exposure altered estrous cyclicity, reduced ovary weight as well as number of antral follicles and corpora lutea. By starting exposure at weaning, we could detect advanced day of VO in DES-exposed animals despite a lower body weight. Some endpoints were affected mainly with adult exposure, as DES increased liver weights in adulthood only. For KTZ, no effects were seen on time of VO, but adrenal and liver weights were increased in both exposure scenarios, and adult KTZ exposure also stimulated ovarian follicle growth. At first glance, this would indicate that a pubertal exposure scenario would be preferrable as timing of VO may serve as sensitive indicator of endocrine disruption by estrogenic mode of action. However, a higher sensitivity for other endocrine targets may be seen starting exposure in adulthood. Overall, starting a 28-day study at weaning with inclusion of VO assessment would mainly be recommended for substances showing estrogenic potential e.g., in vitro, whereas for other substances an adult exposure scenario may be recommended.
- Open Access
- 1 April 2022
- Published by Elsevier in Environmental Pollution
- Vol. 304, 119242
Using alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?
- 1 April 2022
- Published by Elsevier in Environmental Pollution
- Vol. 304, 119242
Open AccessUsing alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?
- Open Access
- 1 June 2021
- Published by Elsevier in Toxicology
- Vol. 458, 152821
Perinatal exposure to known endocrine disrupters alters ovarian development and systemic steroid hormone profile in rats
- 1 June 2021
- Published by Elsevier in Toxicology
- Vol. 458, 152821
Open AccessPerinatal exposure to known endocrine disrupters alters ovarian development and systemic steroid hormone profile in rats
- Open Access
- 27 April 2021
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 182 (1) , 60-69
Effects of the Hedgehog Signaling Inhibitor Itraconazole on Developing Rat Ovaries
Early ovary development is considered to be largely hormone independent; yet, there are associations between fetal exposure to endocrine disrupting chemicals and reproductive disorders in women. This can potentially be explained by perturbations to establishment of ovarian endocrine function rather than interference with an already established hormone system. In this study we explore if Hedgehog (HH) signaling, a central pathway for correct ovary development, can be disrupted by exposure to HH-disrupting chemicals, using the antifungal itraconazole as model compound. In the mouse Leydig cell line TM3, used as a proxy for ovarian theca cells, itraconazole exposure had a suppressing effect on genes downstream of HH signaling, such as Gli1. Exposing explanted rat ovaries (gestational day 22 or postnatal day 3) to 30 µM itraconazole for 72 h induced significant suppression of genes in the HH signaling pathway with altered Ihh, Gli1, Ptch1, and Smo expression similar to those previously observed in Ihh/Dhh knock-out mice. Exposing rat dams to 50 mg/kg bw/day in the perinatal period did not induce observable changes in the offspring’s ovaries. Overall, our results suggest that HH signal disruptors may affect ovary development with potential long-term consequences for female reproductive health. However, potent HH inhibitors would likely cause severe teratogenic effects at doses lower than those causing ovarian dysgenesis, so the concern with respect to reproductive disorder is for the presence of HH disruptors at low concentration in combination with other ovary or endocrine disrupting compounds.
- 27 April 2021
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 182 (1) , 60-69
Open AccessEffects of the Hedgehog Signaling Inhibitor Itraconazole on Developing Rat Ovaries
Early ovary development is considered to be largely hormone independent; yet, there are associations between fetal exposure to endocrine disrupting chemicals and reproductive disorders in women. This can potentially be explained by perturbations to establishment of ovarian endocrine function rather than interference with an already established hormone system. In this study we explore if Hedgehog (HH) signaling, a central pathway for correct ovary development, can be disrupted by exposure to HH-disrupting chemicals, using the antifungal itraconazole as model compound. In the mouse Leydig cell line TM3, used as a proxy for ovarian theca cells, itraconazole exposure had a suppressing effect on genes downstream of HH signaling, such as Gli1. Exposing explanted rat ovaries (gestational day 22 or postnatal day 3) to 30 µM itraconazole for 72 h induced significant suppression of genes in the HH signaling pathway with altered Ihh, Gli1, Ptch1, and Smo expression similar to those previously observed in Ihh/Dhh knock-out mice. Exposing rat dams to 50 mg/kg bw/day in the perinatal period did not induce observable changes in the offspring’s ovaries. Overall, our results suggest that HH signal disruptors may affect ovary development with potential long-term consequences for female reproductive health. However, potent HH inhibitors would likely cause severe teratogenic effects at doses lower than those causing ovarian dysgenesis, so the concern with respect to reproductive disorder is for the presence of HH disruptors at low concentration in combination with other ovary or endocrine disrupting compounds.
- Open Access
- 1 April 2021
- Published by Elsevier in Reproductive Toxicology
- Vol. 101, 9-17
Classical toxicity endpoints in female rats are insensitive to the human endocrine disruptors diethylstilbestrol and ketoconazole
- 1 April 2021
- Published by Elsevier in Reproductive Toxicology
- Vol. 101, 9-17
Open AccessClassical toxicity endpoints in female rats are insensitive to the human endocrine disruptors diethylstilbestrol and ketoconazole
- Open Access
- 1 September 2020
- Published by Elsevier in Environment International
- Vol. 142, 105870
Grouping of endocrine disrupting chemicals for mixture risk assessment – Evidence from a rat study
- 1 September 2020
- Published by Elsevier in Environment International
- Vol. 142, 105870
Open AccessGrouping of endocrine disrupting chemicals for mixture risk assessment – Evidence from a rat study
- Open Access
- 7 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (10) , 3359-3379
Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals
Modern living challenges female reproductive health. We are witnessing a rise in reproductive disorders and drop in birth rates across the world. The reasons for these manifestations are multifaceted and most likely include continuous exposure to an ever-increasing number of chemicals. The cause–effect relationships between chemical exposure and female reproductive disorders, however, have proven problematic to determine. This has made it difficult to assess the risks chemical exposures pose to a woman’s reproductive development and function. To address this challenge, this review uses the adverse outcome pathway (AOP) concept to summarize current knowledge about how chemical exposure can affect female reproductive health. We have a special focus on effects on the ovaries, since they are essential for lifelong reproductive health in women, being the source of both oocytes and several reproductive hormones, including sex steroids. The AOP framework is widely accepted as a new tool for toxicological safety assessment that enables better use of mechanistic knowledge for regulatory purposes. AOPs equip assessors and regulators with a pragmatic network of linear cause–effect relationships, enabling the use of a wider range of test method data in chemical risk assessment and regulation. Based on current knowledge, we propose ten putative AOPs relevant for female reproductive disorders that can be further elaborated and potentially be included in the AOPwiki. This effort is an important step towards better safeguarding the reproductive health of all girls and women.
- 7 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (10) , 3359-3379
Open AccessPutative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals
Modern living challenges female reproductive health. We are witnessing a rise in reproductive disorders and drop in birth rates across the world. The reasons for these manifestations are multifaceted and most likely include continuous exposure to an ever-increasing number of chemicals. The cause–effect relationships between chemical exposure and female reproductive disorders, however, have proven problematic to determine. This has made it difficult to assess the risks chemical exposures pose to a woman’s reproductive development and function. To address this challenge, this review uses the adverse outcome pathway (AOP) concept to summarize current knowledge about how chemical exposure can affect female reproductive health. We have a special focus on effects on the ovaries, since they are essential for lifelong reproductive health in women, being the source of both oocytes and several reproductive hormones, including sex steroids. The AOP framework is widely accepted as a new tool for toxicological safety assessment that enables better use of mechanistic knowledge for regulatory purposes. AOPs equip assessors and regulators with a pragmatic network of linear cause–effect relationships, enabling the use of a wider range of test method data in chemical risk assessment and regulation. Based on current knowledge, we propose ten putative AOPs relevant for female reproductive disorders that can be further elaborated and potentially be included in the AOPwiki. This effort is an important step towards better safeguarding the reproductive health of all girls and women.
- Open Access
- 1 June 2020
- Published by Elsevier in Current Research in Toxicology
- Vol. 1, 116-123
Hedgehog signal disruption, gonadal dysgenesis and reproductive disorders: Is there a link to endocrine disrupting chemicals?
- 1 June 2020
- Published by Elsevier in Current Research in Toxicology
- Vol. 1, 116-123
Open AccessHedgehog signal disruption, gonadal dysgenesis and reproductive disorders: Is there a link to endocrine disrupting chemicals?